chlorpheniramine has been researched along with Colonic Neoplasms in 3 studies
Chlorpheniramine: A histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications. One of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than PROMETHAZINE.
chlorphenamine : A tertiary amino compound that is propylamine which is substituted at position 3 by a pyridin-2-yl group and a p-chlorophenyl group and in which the hydrogens attached to the nitrogen are replaced by methyl groups. A histamine H1 antagonist, it is used to relieve the symptoms of hay fever, rhinitis, urticaria, and asthma.
Colonic Neoplasms: Tumors or cancer of the COLON.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Proliferation of both mouse and human breast cancer cells was inhibited by chlorpheniramine (CPA) in a dose-response manner." | 7.69 | Chlorpheniramine inhibits the synthesis of ornithine decarboxylase and the proliferation of human breast cancer cell lines. ( García de Veas, R; Lozano, J; Medina, MA; Morata, P; Sánchez-Jiménez, F, 1995) |
| " The authors present two cases that appear to be consistent with such a possibility: that of a 63-year-old woman in whom a high-grade angiosarcoma of the forehead improved after discontinuation of lithium therapy and then progressed rapidly when treatment with carbamazepine was started, and that of a 74-year-old woman with metastatic adenocarcinoma of the colon that regressed when self-treatment with a nonprescription decongestant preparation containing antihistamine was discontinued." | 3.69 | Can the clinical course of cancer be influenced by non-antineoplastic drugs? ( Brandes, LJ; Friesen, LA, 1995) |
| "Proliferation of both mouse and human breast cancer cells was inhibited by chlorpheniramine (CPA) in a dose-response manner." | 3.69 | Chlorpheniramine inhibits the synthesis of ornithine decarboxylase and the proliferation of human breast cancer cell lines. ( García de Veas, R; Lozano, J; Medina, MA; Morata, P; Sánchez-Jiménez, F, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morita, T | 1 |
| Tei, Y | 1 |
| Shishido, H | 1 |
| Inoue, S | 1 |
| Brandes, LJ | 1 |
| Friesen, LA | 1 |
| Medina, MA | 1 |
| García de Veas, R | 1 |
| Morata, P | 1 |
| Lozano, J | 1 |
| Sánchez-Jiménez, F | 1 |
3 other studies available for chlorpheniramine and Colonic Neoplasms
| Article | Year |
|---|---|
Chlorpheniramine maleate as an alternative to antiemetic cyclizine.
Topics: Aged; Antiemetics; Chlorpheniramine; Colonic Neoplasms; Cyclizine; Humans; Male; Middle Aged; Nausea | 2004 |
Can the clinical course of cancer be influenced by non-antineoplastic drugs?
Topics: Adenocarcinoma, Mucinous; Aged; Carbamazepine; Cell Division; Chlorpheniramine; Colonic Neoplasms; D | 1995 |
Chlorpheniramine inhibits the synthesis of ornithine decarboxylase and the proliferation of human breast cancer cell lines.
Topics: Animals; Breast Neoplasms; Cell Division; Chlorpheniramine; Colonic Neoplasms; Dose-Response Relatio | 1995 |